NPPA insights

Cholecalciferol 7000 IU chewable tablet priced at ₹8.93

NPPA order S.O. 5999(E) of November 2, 2026 fixes ₹8.93 per tablet, excluding GST, as the retail price of a cholecalciferol 7000 IU chewable tablet. It applies to M/s Windlas Biotech Limited (manufacturer) and M/s Eris Lifesciences Limited (marketing company), for this formulation only.

NPPA · November 2, 2026

Vishnu Gupta

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals of the Ministry of Chemicals and Fertilizers, issued Order S.O. 5999(E) dated November 2, 2026, published the same day in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (ii), No. 5767. It uses the powers in paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013 (DPCO, 2013), read with S.O. 1394(E) of May 30, 2013, S.O. 5249(E) of November 11, 2022 and S.O. 3516(E) of June 30, 2026.

The order fixes ₹8.93 per tablet, exclusive of Goods and Services Tax (GST), as the retail price of Cholecalciferol Tablets, each uncoated chewable tablet containing Cholecalciferol IP 7000 IU. The table names M/s Windlas Biotech Limited and M/s Eris Lifesciences Limited as the manufacturer and marketing company. The order treats the formulation as a "new drug" under paragraph 2(1)(u) of the DPCO, 2013, and the manufacturer must fix its retail price at no more than ₹8.93.

The price applies only to the manufacturer and marketer named in the table. It is subject to all statutory requirements, including "manufacturing license permission" from the Central or State Licensing Authority, as applicable. GST may be added only if it has actually been paid or is payable to the Government. The manufacturer works out the price of a pack under paragraph 11 of the DPCO, 2013, and must issue a price list in Form V under paragraph 24 to NPPA through IPDMS, with a copy to the State Drug Controller and dealers. Retailers and dealers must display the price list where they do business. A company that does not keep to the price must deposit the overcharged amount with interest under the DPCO, 2013 read with the Essential Commodities Act, 1955.

The order does not give a pack size, a maximum retail price for a pack or a date from which the price applies. It does not say when the tablet was launched or why the price was fixed. It is signed by Bhiva Ram Yadav, Assistant Director, under PN/285/153/2026/F/F. No. 8(153)/2026/D.P./NPPA-Div.-II.

Issued by
National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers
Document
Order S.O. 5999(E), under paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013
Dated
November 2, 2026
Published
Gazette of India, Extraordinary, Part II, Section 3, Sub-section (ii), No. 5767, November 2, 2026
Applies to
M/s Windlas Biotech Limited (manufacturer) and M/s Eris Lifesciences Limited (marketing company), for this formulation only
Formulation
Cholecalciferol Tablets: each uncoated chewable tablet contains Cholecalciferol IP 7000 IU
Retail price
₹8.93 per tablet, exclusive of GST
Takes effect
The order states no date
Price list
Form V to NPPA through IPDMS, with a copy to the State Drug Controller and dealers
Signed by
Bhiva Ram Yadav, Assistant Director

The price fixed

Sl. No.Formulation / Brand NameStrengthUnitManufacturer & Marketing CompanyRetail Price (₹)
1Cholecalciferol TabletsEach uncoated chewable tablet contains: Cholecalciferol IP 7000 IU1 TabletM/s Windlas Biotech Limited/ M/s Eris Lifesciences Limited8.93

The order (PDF, 679 KB)

Source: Gazette of India, CG-DL-E-03112026-277617.

Checked against the official copy on November 7, 2026.